Marine Diterpenoids as Potential Anti-Inflammatory Agents

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  González, Yisett ^a,b   Torres Mendoza, Daniel ^a,b   Jones, Gillian E ^a   Fernandez, Patricia L ^a  

^a INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^b ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; BRIARANE DITERPENOID DERIVATIVE; BRIARELLIN DERIVATIVE; CEMBRANE DITERPENOID DERIVATIVE; CURCUMIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DITERPENE GLYCOSIDE DERIVATIVE; DITERPENOID; DOLABELLANE DITERPENOID DERIVATIVE; DRUG METABOLITE; EPIGALLOCATECHIN GALLATE; EUNICELLANE DITERPENOID DERIVATIVE; EXCAVATOLIDE B; FUSCOSIDE B; GLUCOCORTICOID; GLYCOSIDE; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PSEUDOPTERANE DERIVATIVE; UNCLASSIFIED DRUG; ARACHIDONIC ACID; BIOLOGICAL PRODUCT; DITERPENE;

ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; BONE MARROW DERIVED DENDRITIC CELL; CHRONIC INFLAMMATION; CLINICAL STUDY; CORAL; DNA BINDING; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; MARINE SPECIES; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; ANIMAL; ANTHOZOA; CHEMISTRY; INFLAMMATION; METABOLISM; MOUSE;

ANIMALS; ANTHOZOA; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACID; BIOLOGICAL PRODUCTS; DITERPENES; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MICE; NF-KAPPA B;

EID: 84946056525     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/263543     Document Type: Article

References (161)

1. C. N. Serhan and J. Savill, "Resolution of inflammation: The beginning programs the end, " Nature Immunology, vol. 6, no. 12, pp. 1191-1197, 2005.
2. C. N. Serhan, S. D. Brain, C. D. Buckley et al., "Resolution of inflammation: State of the art, definitions and terms, "TheFASEB Journal, vol. 21, no. 2, pp. 325-332, 2007.
3. L. M. Coussens and Z. Werb, "Inflammation and cancer, " Nature, vol. 420, no. 6917, pp. 860-867, 2002.
4. P. Libby, P. M. Ridker, and A. Maseri, "Inflammation and atherosclerosis, " Circulation, vol. 105, no. 9, pp. 1135-1143, 2002.
5. P. Libby, "Inflammation and cardiovascular disease mechanisms, " The American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 456S-460S, 2006.
6. R. A. Medina, D. E. Goeger, P. Hills et al., "Coibamide A, a potent antiproliferative cyclic depsipeptide from the panamanian marine cyanobacterium Leptolyngbya sp., " Journal of the American Chemical Society, vol. 130, no. 20, pp. 6324-6325, 2008.
7. C. C. Hughes, J. B. MacMillan, S. P. Gaudêncio, P. R. Jensen, and W. Fenical, "Theammosamides: Structures of cell cyclemodulators from a marine-derived Streptomyces species, " Angewandte Chemie International Edition, vol. 48, no. 4, pp. 725-727, 2009.
8. T. P. Kondratyuk, E.-J. Park, R. Yu et al., "Novel marine phenazines as potential cancer chemopreventive and antiinflammatory agents, " Marine Drugs, vol. 10, no. 2, pp. 451-464, 2012.
9. J. L. Goldstein andM. S. Brown, "Regulation of the mevalonate pathway, " Nature, vol. 343, no. 6257, pp. 425-430, 1990.
10. B. de las Heras and S. Hortelano, "Molecular basis of the anti-inflammatory effects of terpenoids, " Inflammation and Allergy-Drug Targets, vol. 8, no. 1, pp. 28-39, 2009.
11. J. R. Vane and R. M. Botting, "Anti-inflammatory drugs and their mechanism of action, " Inflammation Research, vol. 47, supplement 2, pp. S78-S87, 1998.
12. O. Llorens, J. J. Perez, A. Palomer, andD. Mauleon, "Differential binding mode of diverse cyclooxygenase inhibitors, " Journal of Molecular Graphics & Modelling, vol. 20, no. 5, pp. 359-371, 2002.
13. W. L. Xie, J. G. Chipman, D. L. Robertson, R. L. Erikson, and D. L. Simmons, "Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 7, pp. 2692-2696, 1991.
14. S. H. Lee, E. Soyoola, P. Chanmugam et al., "Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide, " The Journal of Biological Chemistry, vol. 267, no. 36, pp. 25934-25938, 1992.
15. C. S. Williams, M. Mann, and R. N. DuBois, "The role of cyclooxygenases in inflammation, cancer, and development, " Oncogene, vol. 18, no. 55, pp. 7908-7916, 1999.
16. E. Ricciotti and G. A. FitzGerald, "Prostaglandins and inflammation, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 986-1000, 2011.
17. T. D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell, and J. R. Vane, "Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7563-7568, 1999.
18. J. L. Wallace, W. McKnight, B. K. Reuter, and N. Vergnolle, "NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2, " Gastroenterology, vol. 119, no. 3, pp. 706-714, 2000.
19. C.-C. Chan, S. Boyce, C. Brideau et al., "Rofecoxib [vioxx, MK-0966; 4-(4-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles, " The Journal of Pharmacology and Experimental Therapeutics, vol. 290, no. 2, pp. 551-560, 1999.
20. J. L. Goldstein, F. E. Silverstein, N. M. Agrawal et al., "Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor, " The American Journal of Gastroenterology, vol. 95, no. 7, pp. 1681-1690, 2000.
21. W. A. Ray, C. M. Stein, J. R. Daugherty, K. Hall, P. G. Arbogast, and M. R. Griffin, "COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease, " The Lancet, vol. 360, no. 9339, pp. 1071-1073, 2002.
22. J. P. Tuckermann, A. Kleiman, K. G. McPherson, and H. M. Reichardt, "Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis, " Critical Reviews in Clinical Laboratory Sciences, vol. 42, no. 1, pp. 71-104, 2005.
23. V. M. Keatings, A. Jatakanon, Y. M. Worsdell, and P. J. Barnes, "Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD, " The American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 2, pp. 542-548, 1997.
24. P. Zakroysky, W. Thai, R. C. Deaño et al., "Steroid exposure, acute coronary syndrome, and inflammatory bowel disease: insights into the inflammatory milieu, " The American Journal of Medicine, vol. 128, no. 3, pp. 303-311, 2015.
25. M. Ibañez, A. M. Ortiz, I. Castrejón et al., "A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass, " Arthritis Research & Therapy, vol. 12, no. 2, article R50, 2010.
26. M. Mosca, C. Tani, L. Carli, and S. Bombardieri, "Glucocorticoids in systemic lupus erythematosus, " Clinical and Experimental Rheumatology, vol. 29, supplement 68, no. 5, pp. S126-S129, 2011.
27. L. I. McKay and J. A. Cidlowski, "Molecular control of immune/ inflammatory responses: interactions between nuclear factor-B and steroid receptor-signaling pathways, " Endocrine Reviews, vol. 20, no. 4, pp. 435-459, 1999.
28. K. De Bosscher, W. Vanden Berghe, and G. Haegeman, "The interplay between the glucocorticoid receptor and nuclear factor-B or activator protein-1: Molecular mechanisms for gene repression, " Endocrine Reviews, vol. 24, no. 4, pp. 488-522, 2003.
29. M. S. Hayden and S. Ghosh, "Signaling to NF-B, " Genes & Development, vol. 18, no. 18, pp. 2195-2224, 2004.
30. M. Karin, "Nuclear factor-B in cancer development and progression, " Nature, vol. 441, no. 7092, pp. 431-436, 2006.
31. H. Häcker and M. Karin, "Regulation and function of IKK and IKK-related kinases, " Science's STKE, vol. 2006, no. 357, p. re13, 2006.
32. A. Oeckinghaus, M. S. Hayden, and S. Ghosh, "Crosstalk inNF-B signaling pathways, " Nature Immunology, vol. 12, no. 8, pp. 695-708, 2011.
33. J. W. Pierce, M. A. Read, H. Ding, F. W. Luscinskas, and T. Collins, "Salicylates inhibit IB-phosphorylation, endothelial-leukocyte adhesionmolecule expression, and neutrophil transmigration, " The Journal of Immunology, vol. 156, no. 10, pp. 3961-3969, 1996.
34. M.-J. Yin, Y. Yamamoto, and R. B. Gaynor, "The antiinflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta, " Nature, vol. 396, no. 6706, pp. 77-80, 1998.
35. Y. Yamamoto, M.-J. Yin, K.-M. Lin, and R. B. Gaynor, "Sulindac inhibits activation of the NF-B pathway, " The Journal of Biological Chemistry, vol. 274, no. 38, pp. 27307-27314, 1999.
36. K. S. Berman, U. N. Verma, G. Harburg, J. D. Minna, M. H. Cobb, and R. B. Gaynor, "Sulindac enhances tumor necrosis factor-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-B, " Clinical Cancer Research, vol. 8, no. 2, pp. 354-360, 2002.
37. A. D. Adinoff and J. R. Hollister, "Steroid-induced fractures and bone loss in patients with asthma, "The New England Journal of Medicine, vol. 309, no. 5, pp. 265-268, 1983.
38. J. R. Curtis, A. O. Westfall, J. Allison et al., "Populationbased assessment of adverse events associated with long-term glucocorticoid use, " Arthritis Care & Research, vol. 55, no. 3, pp. 420-426, 2006.
39. W. Ericson-Neilsen and A. D. Kaye, "Steroids: pharmacology, complications, and practice Delivery Issues, " The Ochsner Journal, vol. 14, no. 2, pp. 203-207, 2014.
40. M. Karin, Y. Yamamoto, and Q. M. Wang, "The IKK NF-B system: A treasure trove for drug development, " Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17-26, 2004.
41. J. A. Keifer, D. C. Guttridge, B. P. Ashburner, and A. S. Baldwin Jr., "Inhibition of NF-B activity by thalidomide through suppression of IB kinase activity, " The Journal of Biological Chemistry, vol. 276, no. 25, pp. 22382-22387, 2001.
42. S. Majumdar, B. Lamothe, and B. B. Aggarwal, "Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester, " The Journal of Immunology, vol. 168, no. 6, pp. 2644-2651, 2002.
43. N. Mitsiades, C. S. Mitsiades, V. Poulaki et al., "Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications, " Blood, vol. 99, no. 12, pp. 4525-4530, 2002.
44. M. A. Palladino, F. R. Bahjat, E. A. Theodorakis, and L. L. Moldawer, "Anti-TNF-alpha therapies: The next generation, " Nature Reviews Drug Discovery, vol. 2, no. 9, pp. 736-746, 2003.
45. A. T. Paul, V. M. Gohil, and K. K. Bhutani, "Modulating TNF-signaling with natural products, " Drug Discovery Today, vol. 11, no. 15-16, pp. 725-732, 2006.
46. S. J. Bickston, G. R. Lichtenstein, K. O. Arseneau, R. B. Cohen, and F. Cominelli, "The relationship between infliximab treatment and lymphoma in Crohn's disease, " Gastroenterology, vol. 117, no. 6, pp. 1433-1437, 1999.
47. C. D. Lao, M. T. Ruffin, D. Normolle et al., "Dose escalation of a curcuminoid formulation, " BMC Complementary and Alternative Medicine, vol. 6, article 10, 2006.
48. C. V. Rao, "Regulation ofCOXand LOXby curcumin, " Advances in Experimental Medicine and Biology, vol. 595, pp. 213-226, 2007.
49. M. Shakibaei, T. John, G. Schulze-Tanzil, I. Lehmann, and A. Mobasheri, "Suppression of NF-B activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis, " Biochemical Pharmacology, vol. 73, no. 9, pp. 1434-1445, 2007.
50. C. Csaki, A. Mobasheri, and M. Shakibaei, "Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis, " Arthritis Research andTherapy, vol. 11, no. 6, article R165, 2009.
51. S. C. Gupta, J. H. Kim, S. Prasad, and B. B. Aggarwal, "Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals, " Cancer andMetastasis Reviews, vol. 29, no. 3, pp. 405-434, 2010.
52. T. Kawamori, R. Lubet, V. E. Steele et al., "Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer, " Cancer Research, vol. 59, no. 3, pp. 597-601, 1999.
53. A.-L. Chen, C.-H. Hsu, J.-K. Lin et al., "Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, " Anticancer Research, vol. 21, no. 4, pp. 2895-2900, 2001.
54. Y. Lv, Z. An, H. Chen, Z. Wang, and L. Liu, "Mechanism of curcumin resistance to human cytomegalovirus in HELF cells, " BMC Complementary and Alternative Medicine, vol. 14, article 284, 2014.
55. J. A. Cho and E. Park, "Curcumin utilizes the anti-inflammatory response pathway to protect the intestine against bacterial invasion, " Nutrition Research and Practice, vol. 9, no. 2, pp. 117-122, 2015.
56. P. R. Holt, S. Katz, and R. Kirshoff, "Curcumin therapy in inflammatory bowel disease: A pilot study, " Digestive Diseases and Sciences, vol. 50, no. 11, pp. 2191-2193, 2005.
57. H. Hanai, T. Iida, K. Takeuchi et al., "Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, doubleblind, placebo-controlled trial, " Clinical Gastroenterology and Hepatology, vol. 4, no. 12, pp. 1502-1506, 2006.
58. S. Kumar, V. Ahuja, M. J. Sankar, A. Kumar, and A. C. Moss, "Curcumin for maintenance of remission in ulcerative colitis., " Cochrane Database of Systematic Reviews, vol. 10, Article ID CD008424, 2012.
59. J. M. Weber, A. Ruzindana-Umunyana, L. Imbeault, and S. Sircar, "Inhibition of adenovirus infection and adenain by green tea catechins, " Antiviral Research, vol. 58, no. 2, pp. 167-173, 2003.
60. J.-M. Song, K.-H. Lee, and B.-L. Seong, "Antiviral effect of catechins in green tea on influenza virus, " Antiviral Research, vol. 68, no. 2, pp. 66-74, 2005.
61. K. Kono, I. Tatara, S. Takeda, K. Arakawa, andY. Hara, "Antibacterial activity of epigallocatechin gallate against methicillinresistant Staphylococcus aureus, " Kansenshogaku Zasshi. The Journal of the Japanese Association for Infectious Diseases, vol. 68, no. 12, pp. 1518-1522, 1994.
62. J. Jankun, S. H. Selman, R. Swiercz, and E. Skrzypczak-Jankun, "Why drinking green tea could prevent cancer, " Nature, vol. 387, no. 6633, p. 561, 1997.
63. Y.-C. Wang and U. Bachrach, "The specific anti-cancer activity of green tea (?)-epigallocatechin-3-gallate (EGCG), " Amino Acids, vol. 22, no. 2, pp. 131-143, 2002.
64. T. Hussain, S. Gupta, V. M. Adhami, and H. Mukhtar, "Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells, " International Journal of Cancer, vol. 113, no. 4, pp. 660-669, 2005.
65. R. A. Burgos, J. L. Hancke, J. C. Bertoglio et al., "Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: A prospective randomized placebocontrolled trial, " Clinical Rheumatology, vol. 28, no. 8, pp. 931-946, 2009.
66. Q.-W. Lv, W. Zhang, Q. Shi et al., "Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): A randomised, controlled clinical trial, " Annals of the Rheumatic Diseases, vol. 74, no. 6, pp. 1078-1086, 2015.
67. J. T. Coon and E. Ernst, "Andrographis paniculata in the treatment of upper respiratory tract infections: A systematic review of safety and efficacy, " Planta Medica, vol. 70, no. 4, pp. 293-298, 2004.
68. J. Ren, Q. Tao, X. Wang, Z. Wang, and J. Li, "Efficacy of T2 in active Crohn's disease: A prospective study report, " Digestive Diseases and Sciences, vol. 52, no. 8, pp. 1790-1797, 2007.
69. A. M. Brinker, J. Ma, P. E. Lipsky, and I. Raskin, "Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae), " Phytochemistry, vol. 68, no. 6, pp. 732-766, 2007.
70. S.-L. Wu, J.-H. Su, Z.-H. Wen et al., "Simplexins A-I, eunicellinbased diterpenoids fromthe soft coral Klyxumsimplex, " Journal of Natural Products, vol. 72, no. 6, pp. 994-1000, 2009.
71. B.-W. Chen, S.-M. Chang, C.-Y. Huang et al., "Hirsutalins AH, eunicellin-based diterpenoids from the soft coral Cladiella hirsuta, " Journal of Natural Products, vol. 73, no. 11, pp. 1785-1791, 2010.
72. B.-W. Chen, C.-H. Chao, J.-H. Su, Z.-H. Wen, P.-J. Sung, and J.-H. Sheu, "Anti-inflammatory eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex, " Organic & Biomolecular Chemistry, vol. 8, no. 10, pp. 2363-2366, 2010.
73. C.-J. Tai, J.-H. Su, M.-S. Huang, Z.-H. Wen, C.-F. Dai, and J.-H. Sheu, "Bioactive eunicellin-based diterpenoids from the soft coral Cladiella krempfi, " Marine Drugs, vol. 9, no. 10, pp. 2036-2045, 2011.
74. F.-J. Hsu, B.-W. Chen, Z.-H. Wen et al., "Klymollins A-H, bioactive eunicellin-based diterpenoids from the formosan soft coral Klyxum molle, " Journal of Natural Products, vol. 74, no. 11, pp. 2467-2471, 2011.
75. B.-W. Chen, C.-H. Chao, J.-H. Su et al., "Klysimplexins IT, eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex, " Organic and Biomolecular Chemistry, vol. 9, no. 3, pp. 834-844, 2011.
76. S.-L. Wu, J.-H. Su, C.-Y. Huang et al., "Simplexins P-S, eunicellin-based diterpenes from the soft coral Klyxum simplex, " Marine Drugs, vol. 10, no. 6, pp. 1203-1211, 2012.
77. C.-J. Tai, J.-H. Su, C.-Y. Huang et al., "Cytotoxic and antiinflammatory eunicellin-based diterpenoids fromthe soft coral Cladiella krempfi, "MarineDrugs, vol. 11, no. 3, pp. 788-799, 2013.
78. B.-W. Chen, S.-Y. Wang, C.-Y. Huang, S.-L. Chen, Y.-C. Wu, and J.-H. Sheu, "Hirsutalins I-M, eunicellin-based diterpenoids from the soft coral Cladiella hirsuta, " Tetrahedron, vol. 69, no. 10, pp. 2296-2301, 2013.
79. F.-Y. Chang, F.-J. Hsu, C.-J. Tai, W.-C. Wei, N.-S. Yang, and J.-H. Sheu, "Klymollins T-X, bioactive eunicellin-based diterpenoids from the soft coral Klyxum molle, " Marine Drugs, vol. 12, no. 5, pp. 3060-3071, 2014.
80. Y.-H. Chen, C.-Y. Tai, Y.-H. Kuo et al., "Cladieunicellins A-E, new eunicellins from an Indonesian soft coral Cladiella sp., " Chemical & Pharmaceutical Bulletin, vol. 59, no. 3, pp. 353-358, 2011.
81. Y.-H. Chen, T.-L. Hwang, Y.-D. Su et al., "New 6-hydroxyeunicellins from a soft coral Cladiella sp., " Chemical & Pharmaceutical Bulletin, vol. 60, no. 1, pp. 160-163, 2012.
82. Y.-N. Lee, C.-J. Tai, T.-L. Hwang, and J.-H. Sheu, "Krempfielins J-M, new eunicellin-based diterpenoids from the soft coral cladiella krempfi, " Marine Drugs, vol. 11, no. 8, pp. 2741-2750, 2013.
83. M.-C. Lin, B.-W. Chen, C.-Y. Huang, C.-F. Dai, T.-L. Hwang, and J.-H. Sheu, "Eunicellin-based diterpenoids from the formosan soft coral Klyxum molle with inhibitory activity on superoxide generation and elastase release by neutrophils, " Journal of Natural Products, vol. 76, no. 9, pp. 1661-1667, 2013.
84. Y.-N. Lee, C.-J. Tai, T.-L. Hwang, and J.-H. Sheu, "Krempfielins N-P, new anti-inflammatory eunicellins from a Taiwanese soft coral Cladiella krempfi, " Marine Drugs, vol. 12, no. 2, pp. 1148-1156, 2014.
85. C.-J. Tai, U. Chokkalingam, Y. Cheng et al., "KrempfielinsQand R, two new eunicellin-based diterpenoids from the soft coral cladiella krempfi, " International Journal of Molecular Sciences, vol. 15, no. 12, pp. 21865-21874, 2014.
86. T.-Z. Huang, B.-W. Chen, C.-Y. Huang, T.-L. Hwang, C.-F. Dai, and J.-H. Sheu, "Eunicellin-based diterpenoids, hirsutalins NR, fromthe formosan soft coral Cladiella hirsuta, "MarineDrugs, vol. 12, no. 5, pp. 2446-2457, 2014.
87. T.-Z. Huang, B.-W. Chen, C.-Y. Huang et al., "Eunicellin-based diterpenoids, hirsutalins S-V, from the formosan soft coral Cladiella hirsuta, " Marine Drugs, vol. 13, no. 5, pp. 2757-2769, 2015.
88. J. F. Gómez-Reyes, A. Salazar, H. M. Guzmán et al., "secobriarellinone and briarellin S, two new eunicellin-based diterpenoids fromthe panamanian octocoral Briareum asbestinum, " Marine Drugs, vol. 10, no. 11, pp. 2608-2617, 2012.
89. J.-H. Sheu, Y.-H. Chen, Y.-H. Chen et al., "Briarane diterpenoids isolated from gorgonian corals between 2011 and 2013, " Marine Drugs, vol. 12, no. 4, pp. 2164-2181, 2014.
90. Y.-C. Shen, Y.-H. Chen, T.-L. Hwang, J.-H. Guh, and A. T. Khalil, "Four new briarane diterpenoids from the gorgonian coral Junceella fragilis, " Helvetica Chimica Acta, vol. 90, no. 7, pp. 1391-1398, 2007.
91. C.-C. Liaw, Y.-C. Shen, Y.-S. Lin, T.-L. Hwang, Y.-H. Kuo, andA. T. Khalil, "Frajunolides E-K, briarane diterpenes fromJunceella fragilis, " Journal of Natural Products, vol. 71, no. 9, pp. 1551-1556, 2008.
92. S.-S. Wang, Y.-H. Chen, J.-Y. Chang et al., "Juncenolides H-K, new briarane diterpenoids from Junceella juncea, " Helvetica Chimica Acta, vol. 92, no. 10, pp. 2092-2100, 2009.
93. C.-C. Liaw, Y.-H. Kuo, Y.-S. Lin, T.-L. Hwang, and Y.-C. Shen, "Frajunolides L-O, four new 8-Hydroxybriarane diterpenoids from the Gorgonian Junceella fragilis, " Marine Drugs, vol. 9, no. 9, pp. 1477-1486, 2011.
94. P.-H. Hong, Y.-D. Su, N.-C. Lin et al., "Briarenolide E: The first 2-ketobriarane diterpenoid froman octocoral Briareum sp. (Briareidae), " Tetrahedron Letters, vol. 53, no. 14, pp. 1710-1712, 2012.
95. P.-H. Hong, Y.-D. Su, J.-H. Su et al., "Briarenolides F andG, new briarane diterpenoids from a Briareum sp. octocoral, " Marine Drugs, vol. 10, no. 5, pp. 1156-1168, 2012.
96. Y.-D. Su, T.-L. Hwang, N.-C. Lin et al., "Briarenolides H and I: New 8-hydroxybriarane diterpenoids from a formosan octocoral Briareum sp. (Briareidae), " Bulletin of the Chemical Society of Japan, vol. 85, no. 9, pp. 1031-1036, 2012.
97. C.-C. Liaw, Y.-C. Lin, Y.-S. Lin, C.-H. Chen, T.-L. Hwang, and Y.-C. Shen, "Four new briarane diterpenoids from Taiwanese Gorgonian Junceella fragilis, " Marine Drugs, vol. 11, no. 6, pp. 2042-2053, 2013.
98. Y.-D. Su, C.-H. Cheng, W.-F. Chen et al., "Briarenolide J, the first 12-chlorobriarane diterpenoid from an octocoral Briareum sp. (Briareidae), " Tetrahedron Letters, vol. 55, no. 44, pp. 6065-6067, 2014.
99. J.-Y. Chang, C.-C. Liaw, A. E. Fazary, T.-L. Hwang, and Y.-C. Shen, "New briarane diterpenoids from the gorgonian coral Junceella juncea, " Marine Drugs, vol. 10, no. 6, pp. 1321-1330, 2012.
100. P.-J. Sung, C.-H. Pai, T.-L. Hwang et al., "Junceols D-H, new polyoxygenated briaranes from sea whip gorgonian coral Junceella juncea (Ellisellidae), " Chemical & Pharmaceutical Bulletin, vol. 56, no. 9, pp. 1276-1281, 2008.
101. P.-J. Sung, C.-H. Pai, Y.-D. Su et al., "New 8-hydroxybriarane diterpenoids fromthe gorgonians Junceella juncea and Junceella fragilis (Ellisellidae), " Tetrahedron, vol. 64, no. 19, pp. 4224-4232, 2008.
102. A. Bahl, S. M. Jachak, K. Palaniveloo, T. Ramachandram, C. S. Vairappan, and H. K. Chopra, "2-acetoxyverecynarmin C, a new briarane COX inhibitory diterpenoid from Pennatula aculeata, " Natural Product Communications, vol. 9, no. 8, pp. 1139-1141, 2014.
103. Y.-D. Su, T.-R. Su, Z.-H. Wen et al., "Briarenolides K and L, new anti-inflammatory briarane diterpenoids from an octocoral Briareum sp. (briareidae), " Marine Drugs, vol. 13, no. 2, pp. 1037-1050, 2015.
104. W.-C. Wei, S.-Y. Lin, Y.-J. Chen et al., "Topical application of marine briarane-type diterpenes effectively inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and dermatitis inmurine skin, " Journal of Biomedical Science, vol. 18, no. 1, article 94, 2011.
105. B. Yang, X.-F. Zhou, X.-P. Lin et al., "Cembrane diterpenes chemistry and biological properties, " Current Organic Chemistry, vol. 16, no. 12, pp. 1512-1539, 2012.
106. W.-C. Wei, P.-J. Sung, C.-Y. Duh, B.-W. Chen, J.-H. Sheu, and N.-S. Yang, "Anti-inflammatory activities of natural products isolated from soft corals of Taiwan between 2008 and 2012, " Marine Drugs, vol. 11, no. 10, pp. 4083-4126, 2013.
107. Z. Xi, W. Bie, W. Chen et al., "Sarcophyolides B-E, new cembranoids from the soft coral Sarcophyton elegans, " Marine Drugs, vol. 11, no. 9, pp. 3186-3196, 2013.
108. S.-K. Wang, M.-K. Hsieh, and C.-Y. Duh, "New diterpenoids from soft coral Sarcophyton ehrenbergi, " Marine Drugs, vol. 11, no. 11, pp. 4318-4327, 2013.
109. A. F. Ahmed, Z.-H. Wen, J.-H. Su et al., "Oxygenated cembranoids from a Formosan soft coral Sinularia gibberosa, " Journal of Natural Products, vol. 71, no. 2, pp. 179-185, 2008.
110. A. F. Ahmed, S.-H. Tai, Z.-H. Wen et al., "A C-3 methylated isocembranoid and 10-oxocembranoids from a formosan soft coral, Sinularia grandilobata, " Journal of Natural Products, vol. 71, no. 6, pp. 946-951, 2008.
111. Y. Lu, C.-Y. Huang, Y.-F. Lin et al., "Anti-inflammatory cembranoids from the soft corals Sinularia querciformis and Sinularia granosa, " Journal of Natural Products, vol. 71, no. 10, pp. 1754-1759, 2008.
112. C.-H. Chao, Z.-H. Wen, Y.-C. Wu, H.-C. Yeh, and J.-H. Sheu, "Cytotoxic and anti-inflammatory cembranoids from the soft coral Lobophytum crassum, " Journal of Natural Products, vol. 71, no. 11, pp. 1819-1824, 2008.
113. S.-Y. Cheng, Z.-H. Wen, S.-F. Chiou et al., "Durumolides AE, anti-inflammatory and antibacterial cembranolides from the soft coral Lobophytum durum, " Tetrahedron, vol. 64, no. 41, pp. 9698-9704, 2008.
114. S.-Y. Cheng, Z.-H. Wen, S.-K. Wang et al., "Anti-inflammatory cembranolides from the soft coral Lobophytum durum, " Bioorganic& Medicinal Chemistry, vol. 17, no. 11, pp. 3763-3769, 2009.
115. Y. Lu, J.-H. Su, C.-Y. Huang et al., "Cembranoids from the soft corals sinularia granosa and sinularia querciformis, " Chemical & Pharmaceutical Bulletin, vol. 58, no. 4, pp. 464-466, 2010.
116. W.-Y. Lin, J.-H. Su, Y. Lu et al., "Cytotoxic and antiinflammatory cembranoids from the Dongsha Atoll soft coral Sarcophyton crassocaule, " Bioorganic & Medicinal Chemistry, vol. 18, no. 5, pp. 1936-1941, 2010.
117. W.-Y. Lin, Y. Lu, J.-H. Su et al., "Bioactive cembranoids fromthe dongsha atoll soft coral Sarcophyton crassocaule, " Marine Drugs, vol. 9, no. 6, pp. 994-1006, 2011.
118. C.-H. Chao, K.-J. Chou, C.-Y. Huang et al., "Bioactive cembranoids fromthe soft coral Sinularia crassa, " Marine Drugs, vol. 9, no. 10, pp. 1955-1968, 2011.
119. W.-Y. Lin, Y. Lu, B.-W. Chen et al., "Sarcocrassocolides MO, bioactive cembranoids from the Dongsha Atoll soft coral Sarcophyton crassocaule, " Marine Drugs, vol. 10, no. 3, pp. 617-626, 2012.
120. W.-Y. Lin, B.-W. Chen, C.-Y. Huang et al., "Bioactive cembranoids, sarcocrassocolides P-R, from the Dongsha Atoll soft coral Sarcophyton crassocaule, " Marine Drugs, vol. 12, no. 2, pp. 840-850, 2014.
121. T.-H. Hsiao, C.-S. Sung, Y.-H. Lan et al., "Anti-inflammatory cembranes from the cultured soft coral Nephthea columnaris, " Marine Drugs, vol. 13, no. 6, pp. 3443-3453, 2015.
122. T. Oda, W. Wewengkang, M. M. Kapojos, R. P. Mangindaan, J.-S. Lee, andM. Namikoshi, "Lobohedleolide induces interleukin-8 production in LPS-stimulated humanmonocytic cell line THP-1, " International Journal of Applied Research in Natural Products, vol. 4, no. 3, pp. 16-21, 2011.
123. T. H. Quang, T. T. Ha, C. V. Minh et al., "Cytotoxic and anti-inflammatory cembranoids from the Vietnamese soft coral Lobophytum laevigatum, " Bioorganic and Medicinal Chemistry, vol. 19, no. 8, pp. 2625-2632, 2011.
124. N. X. Cuong, N. P. Thao, B. T. T. Luyenet al., "Cembranoidditerpenes from the soft coral lobophytum crassum and their antiinflammatory activities, " Chemical & Pharmaceutical Bulletin, vol. 62, no. 2, pp. 203-208, 2014.
125. N. P. Thao, B. T. T. Luyen, N. T. T. Ngan et al., "New antiinflammatory cembranoid diterpenoids from the Vietnamese soft coral Lobophytum crassum, " Bioorganic &Medicinal Chemistry Letters, vol. 24, no. 1, pp. 228-232, 2014.
126. N. P. Thao, N. H. Nam, N. X. Cuong et al., "Inhibition of NF-B transcriptional activation in HepG2 cells by diterpenoids from the soft coral Sinularia maxima, " Archives of Pharmacal Research, vol. 37, no. 6, pp. 706-712, 2014.
127. M. M. Kapojos, J.-S. Lee, T. Oda et al., "Two unprecedented cembrene-type terpenes froman indonesian soft coral sarcophyton sp., " Tetrahedron, vol. 66, no. 3, pp. 641-645, 2010.
128. B. König, F. Steinbach, B. Janocha et al., "The differential expression of proinflammatory cytokines IL-6, IL-8 and TNFalpha in renal cell carcinoma, " Anticancer Research, vol. 19, no. 2 C, pp. 1519-1524, 1999.
129. G. Galffy, K. A. Mohammed, P. A. Dowling, N. Nasreen, M. J. Ward, and V. B. Antony, "Interleukin 8: An autocrine growth factor for malignant mesothelioma, " Cancer Research, vol. 59, no. 2, pp. 367-371, 1999.
130. A. R. Green, V. L. Green, M. C. White, andV. Speirs, "Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours, " International Journal of Cancer, vol. 72, no. 6, pp. 937-941, 1997.
131. N. P. Thao, N. H. Nam, N. X. Cuong et al., "Diterpenoids from the soft coral Sinularia maxima and their inhibitory effects on lipopolysaccharide-stimulated production of proinflammatory cytokines in bone marrow-derived dendritic cells, " Chemical & Pharmaceutical Bulletin, vol. 60, no. 12, pp. 1581-1589, 2012.
132. F. Berrué, M. W. B. McCulloch, and R. G. Kerr, "Marine diterpene glycosides, " Bioorganic&Medicinal Chemistry, vol. 19, no. 22, pp. 6702-6719, 2011.
133. S. A. Look, W. Fenical, G. K. Matsumoto, and J. Clardy, "The pseudopterosins: A new class of antiinflammatory and analgesic diterpene pentosides from the marine sea whip Pseudopterogorgia elisabethae (Octocorallia), " The Journal of Organic Chemistry, vol. 51, no. 26, pp. 5140-5145, 1986.
134. I. I. Rodr?guez, Y.-P. Shi, O. J. Garca et al., "New pseudopterosin and seco-pseudopterosin diterpene glycosides from two Colombian isolates of Pseudopterogorgia elisabethae and their diverse biological activities, " Journal of Natural Products, vol. 67, no. 10, pp. 1672-1680, 2004.
135. A. M. S. Mayer, P. B. Jacobson, W. Fenical, R. S. Jacobs, and K. B. Glaser, "Pharmacological characterization of the pseudopterosins: Novel anti-inflammatory natural products isolated from the caribbean soft coral, Pseudopterogorgia elisabethae, " Life Sciences, vol. 62, no. 26, pp. 401-407, 1998.
136. C. E. Moya and R. S. Jacobs, "Pseudopterosin A inhibits phagocytosis and alters intracellular calcium turnover in a pertussis toxin sensitive site in Tetrahymena thermophila, " Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 143, no. 4, pp. 436-443, 2006.
137. V. Roussis, Z. Wu, W. Fenical, S. A. Strobel, G. D. Van Duyne, and J. Clardy, "Newantiinflammatory pseudopterosins fromthe marine octocoral Pseudopterogorgia elisabethae, " The Journal of Organic Chemistry, vol. 55, no. 16, pp. 4916-4922, 1990.
138. A. Ata, R. G. Kerr, C. E. Moya, and R. S. Jacobs, "Identification of anti-inflammatory diterpenes from the marine gorgonian Pseudopterogorgia elisabethae, " Tetrahedron, vol. 59, no. 23, pp. 4215-4222, 2003.
139. H. Correa, A. L. Valenzuela, L. F. Ospina, and C. Duque, "Anti-inflammatory effects of the gorgonian Pseudopterogorgia elisabethae collected at the Islands of Providencia and San Andrés (SWCaribbean), " Journal of Inflammation, vol. 6, article 5, 2009.
140. W. Zhong, C. Moya, R. S. Jacobs, and R. D. Little, "Synthesis and an evaluation of the bioactivity of the C-glycoside of pseudopterosin A methyl ether, " The Journal of Organic Chemistry, vol. 73, no. 18, pp. 7011-7016, 2008.
141. V. M. Tanis, C. Moya, R. S. Jacobs, and R. D. Little, "Synthesis and evaluation of the bioactivity of simplified analogs of the seco-pseudopterosins; progress toward determining a pharmacophore, " Tetrahedron, vol. 64, no. 47, pp. 10649-10663, 2008.
142. F. Flachsmann, K. Schellhaas, C. E. Moya, R. S. Jacobs, and W. Fenical, "Synthetic pseudopterosin analogues: A novel class of antiinflammatory drug candidates, " Bioorganic & Medicinal Chemistry, vol. 18, no. 23, pp. 8324-8333, 2010.
143. D. S. Scherl, J. Afflitto, andA. Gaffar, "Influence of OAS-1000 on mediators of inflammation, " Journal of Clinical Periodontology, vol. 26, no. 4, pp. 246-251, 1999.
144. A. Kijjoa and P. Sawangwong, "Drugs and cosmetics from the sea, " Marine Drugs, vol. 2, no. 2, pp. 73-82, 2004.
145. J. Shin and W. Fenical, "Fuscosides A-D: Antiinflammatory diterpenoid glycosides of new structural classes from the Caribbean gorgonian Eunicea fusca, " The Journal of Organic Chemistry, vol. 56, no. 9, pp. 3153-3158, 1991.
146. P. B. Jacobson and R. S. Jacobs, "Fuscoside: An antiinflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part I: physiological and biochemical studies in murine inflammatory models, " Journal of Pharmacology and Experimental Therapeutics, vol. 262, no. 2, pp. 866-873, 1992.
147. P. B. Jacobson and R. S. Jacobs, "Fuscoside: An anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: biochemical studies in the human neutrophil, " Journal of Pharmacology and Experimental Therapeutics, vol. 262, no. 2, pp. 874-882, 1992.
148. D. H. Marchbank, F. Berrue, and R. G. Kerr, "Eunicidiol, an antiinflammatory dilophol diterpene fromEunicea fusca, " Journal of Natural Products, vol. 75, no. 7, pp. 1289-1293, 2012.
149. O. M. Cóbar, A. D. Rodr?guez, O. L. Padilla, and J. A. Sánchez, "The calyculaglycosides: dilophol-type diterpene glycosides exhibiting antiinflammatory activity from the Caribbean gorgonian Eunicea sp., " The Journal of Organic Chemistry, vol. 62, no. 21, pp. 7183-7188, 1997.
150. Y. Lin, C. A. Bewley, and D. J. Faulkner, "The valdivones, antiinflammatory diterpene esters fromthe SouthAfrican soft coral alcyoniumvaldivae, " Tetrahedron, vol. 49, no. 36, pp. 7977-7984, 1993.
151. W. Fenical, "Marine soft corals of the genus pseudopterogorgia: A resource for novel anti-inflammatory diterpenoids, " Journal of Natural Products, vol. 50, no. 6, pp. 1001-1008, 1987.
152. M. M. Bandurraga, W. Fenical, S. F. Donovan, and J. Clardy, "Pseudopterolide, an irregular diterpenoid with unusual cytotoxic properties from theCaribbean seawhip Pseudopterogorgia acerosa (Pallas) (Gorgonacea), " Journal of the American Chemical Society, vol. 104, no. 23, pp. 6463-6465, 1982.
153. S. A. Look, M. T. Burch, W. Fenical, Z. Qi-tai, and J. Clardy, "Kallolide A, a new antiinflammatory diterpenoid, and related lactones from the Caribbean octocoral Pseudopterogorgia kallos (Bielschowsky), " The Journal of Organic Chemistry, vol. 50, no. 26, pp. 5741-5746, 1985.
154. W. F. Tinto, L. John, W. F. Reynolds, and S. McLean, "Novel pseudopteranoids of Pseudopterogorgia acerosa, " Tetrahedron, vol. 47, no. 41, pp. 8679-8686, 1991.
155. Y. González, D. Doens, R. Santamar?a et al., "A pseudopterane diterpene isolated fromthe octocoral Pseudopterogorgia acerosa inhibits the inflammatory response mediated by TLR-ligands and TNF-alpha in macrophages, " PLoS ONE, vol. 8, no. 12, Article ID e84107, 2013.
156. S.-Y. Cheng, E.-H. Lin, Z.-H. Wen, M. Y.-N. Chiang, and C.-Y. Duh, "Two new verticillane-type diterpenoids from the formosan soft coral Cespitularia hypotentaculata, " Chemical & Pharmaceutical Bulletin, vol. 58, no. 6, pp. 848-851, 2010.
157. S.-Y. Cheng, C.-T. Chuang, Z.-H. Wen et al., "Bioactive norditerpenoids from the soft coral Sinularia gyrosa, " Bioorganic & Medicinal Chemistry, vol. 18, no. 10, pp. 3379-3386, 2010.
158. R. Chatter, R. B. Othman, S. Rabhi et al., "In vivo and in vitro anti-inflammatory activity of neorogioltriol, a new diterpene extracted from the red algae Laurencia glandulifera, " Marine Drugs, vol. 9, no. 7, pp. 1293-1306, 2011.
159. J. P. Barbosa, R. C. Pereira, J. L. Abrantes et al., "In vitro antiviral diterpenes from the Brazilian brown alga Dictyota pfaffii, " Planta Medica, vol. 70, no. 9, pp. 856-860, 2004.
160. D. C. Soares, T. C. Calegari-Silva, U. G. Lopes et al., "Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis, " PLoS Neglected Tropical Diseases, vol. 6, no. 9, Article ID e1787, 2012.
161. M. C. Leal, R. Calado, C. Sheridan, A. Alimonti, and R. Osinga, "Coral aquaculture to support drug discovery, " Trends in Biotechnology, vol. 31, no. 10, pp. 555-561, 2013.